These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 643153

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Homovanillic acid and 5--hydroxy-indoleacetic acid in the cerebrospinal fluid of man--concentration gradients between lumbar and ventricular CSF and variations in ventricular CSF-- (author's transl)].
    Inagawa T, Kajihara S, Okada Y, Yoshimoto H, Mori S, Ishikawa S, Uozumi T.
    No To Shinkei; 1978 May; 30(5):565-74. PubMed ID: 666924
    [No Abstract] [Full Text] [Related]

  • 5. Homovanillic acid and 5-hydroxyindoleacetic acid in lumbar cerebrospinal fluid of patients with acute cerebrovascular lesion.
    Livrea P, Papagno G, Di Reda L, Centrone G.
    Acta Neurol (Napoli); 1976 May; 31(5):647-51. PubMed ID: 1015387
    [No Abstract] [Full Text] [Related]

  • 6. [The monamine metabolites in the CSF of the patients with spinocerebellar degeneration and motor neuron disease (author's transl)].
    Yamamoto M.
    Rinsho Shinkeigaku; 1980 Jul; 20(7):503-9. PubMed ID: 6161732
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effects of reserpine, L-dopa and 5-hydroxytryptophan on 5-hydroxyindoleacetic and homovanillic acids in cerebrospinal fluid, behaviour and EEG in cats.
    Buckingham RL, Radulovacki M.
    Neuropharmacology; 1976 Jul; 15(7):389-92. PubMed ID: 1086441
    [No Abstract] [Full Text] [Related]

  • 9. Effect of ischemia on monoamine metabolism. Brain monoamine metabolites in cerebrospinal fluid of patients with recent cerebral infarction.
    Stelmasiak Z.
    Neuropatol Pol; 1982 Jul; 20(1-2):97-105. PubMed ID: 6191248
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of non-fluctuating progressive dystonia: a neuropharmacological approach.
    Willemse J, van Nieuwenhuizen O, Gooskens RH, Westenberg HG.
    Neuropediatrics; 1984 Oct; 15(4):208-10. PubMed ID: 6208504
    [Abstract] [Full Text] [Related]

  • 12. Correlation of clinical symptoms, HVA and 5-HIAA in csf and plasma L-DOPA in Parkinsonian patients treated with L-DOPA and L-DOPA + RO 4-4602.
    Campanella G, Algeri S, Cerletti C, Dolfini E, Jori A, Rinaldi F.
    Eur J Clin Pharmacol; 1977 Apr 20; 11(4):255-61. PubMed ID: 862646
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Gradients of biogenic amine metabolites in cerebrospinal fluid.
    Siever L, Kraemer H, Sack R, Angwin P, Berger P, Zarcone V, Barchas J, Brodie HK.
    Dis Nerv Syst; 1975 Jan 20; 36(1):13-6. PubMed ID: 1109880
    [No Abstract] [Full Text] [Related]

  • 17. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE, Foxx JL, Butler IJ.
    Ann Neurol; 1980 Jul 20; 8(1):38-42. PubMed ID: 6157351
    [Abstract] [Full Text] [Related]

  • 18. Acidic metabolites of dopamine and serotonin in cerebrospinal fluid.
    Sourkes TL.
    Adv Neurol; 1974 Jul 20; 5():271-3. PubMed ID: 4440576
    [No Abstract] [Full Text] [Related]

  • 19. Overnight sleep EEG and cerebrospinal fluid monoamines in seizures induced by movement.
    Fukuyama Y, Ochiai Y, Hayakawa T, Miyagawa F.
    Neuropadiatrie; 1979 May 20; 10(2):138-49. PubMed ID: 226908
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.